Dashboard
Transactions
Sign in
Create account
← All stocks
TELA Bio, Inc.
TELA
Net buying
CIK 0001561921
#4919 in the set
updated 21 Sep 2026
1 month
12 months
120 months
Bought (1 mo)
$167.24K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$167.24K
+$167.24K against sales at will
By person
19 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Capper Joseph H
Director
$167.24K
(4)
—
+$167.24K
179,827
0.4006%
$219.60K
—
EW HEALTHCARE PARTNERS FUND 2, L.P.
entity
10% owner
—
—
—
7,714,709
17.18%
$9.42M
+87.7%
KOBLISH ANTONY
Chief Executive Officer
—
—
—
586,210
1.31%
$715.88K
+168.7%
Getz Heather C
Chief Executive Officer
—
—
—
532,500
1.19%
$650.29K
+10,550%
Cuca Roberto
COO and CFO
—
—
—
257,377
0.5733%
$314.31K
+173.3%
Blizard Jeffrey
President
—
—
—
205,125
0.4569%
$250.50K
+3,118%
Talmo Paul
Chief Technology Officer
—
—
—
173,436
0.3863%
$211.80K
+151.9%
Firestone Gregory A.
Chief Business Officer
—
—
—
139,307
0.3103%
$170.12K
+164.1%
Smeykal Megan
Chief Accounting Officer
—
—
—
66,873
0.1490%
$81.67K
+122.3%
Plovanic William J.
Director
—
—
—
44,530
0.0992%
$54.38K
—
THOMAS PAUL
Director
—
—
—
23,600
0.0526%
$28.82K
—
NEELS GUIDO J
Director
—
—
—
23,600
0.0526%
$28.82K
—
NOHRA GUY P
Director
—
—
—
23,600
0.0526%
$28.82K
—
Rocchio Betty Jo
Director
—
—
—
23,600
0.0526%
$28.82K
—
Burgess Vincent J
Director
—
—
—
23,330
0.0520%
$28.49K
+51.7%
O'Brien Federica F.
Director
—
—
—
18,470
0.0411%
$22.56K
+75.6%
EVANS DOUGLAS G
Director
—
—
—
18,470
0.0411%
$22.56K
+75.6%
Azarbarzin Kurt
Director
—
—
—
18,470
0.0411%
$22.56K
+75.6%
COLLERAN LISA N
Director
—
—
—
18,470
0.0411%
$22.56K
+75.6%
Individual transactions
0
Everything
Bought
Sold at will
On a plan
Out of an exercise
Exercised, kept
Nothing of that kind in this period.
What was left out
Form 4 filings counted
2
Amendments (4/A) skipped
0
Filings about a different issuer
0
Unreadable filings
0
Joint filings
0
Sales on a Rule 10b5-1 plan
0
Sales straight out of an exercise
0
Sales at will
0
Transactions with no price
0
Shares from compensation/vesting
0
History held since
13 Nov 2019